RESUMO
BACKGROUND: COVID-19 caused by SARS-CoV-2 was declared as a global pandemic by the WHO. Famotidine is a histamine-2 (H2) receptor antagonist which blocks the H2 receptors in the parietal cells, decreasing gastric acid secretion. Our review aims to study all the available scientific evidence on famotidine research outcomes systematically to introspect its clinical efficacy and probable mechanisms and clinical efficacy against SARS-CoV-2. METHODOLOGY: An electronic search of PubMed, Scopus and Google Scholar was performed using MeSH terms "SARS CoV-2" OR "COVID-19" AND"FAMOTIDINE". Relevant informationwas extracted from studies reporting the efficacy of famotidine in COVID-19. RESULTS: We found a total of 32 studies, out of which only 14 were relevant and were included in our review.Molecular computational studies showed that famotidine selectively acts on viral replication proteases papain-like protease (PLpro) and 3-chymotrypsin-like protease (3CLpro). Additionally, it acts via inverse-agonism on the H2 receptors present in neutrophils and eosinophils which leads to inhibition of cytokine release. Clinical study findings have pointed toward significant improvements in COVID-19 patient-reported symptoms in non-hospitalized patients and reduction in intubation or death in critically ill patients associated with the usage of famotidine. However,in one of the studies,famotidine has failed to show any significant benefit in reducing mortality due to COVID-19. CONCLUSION: Famotidine has the potential to answer the ongoing global challenge owing to its selective action on viral replication. Additionally, clinical findings in COVID-19 patients support its efficacy to reduce clinical symptoms of COVID-19.We suggest that further optimally powered randomized clinical trials should be carried out to come up with definitive conclusions.
Assuntos
Tratamento Farmacológico da COVID-19 , Reposicionamento de Medicamentos , Famotidina/uso terapêutico , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , COVID-19/imunologia , COVID-19/mortalidade , COVID-19/virologia , Citocinas/metabolismo , Avaliação Pré-Clínica de Medicamentos , Famotidina/farmacologia , Antagonistas dos Receptores H2 da Histamina/farmacologia , Humanos , Simulação de Acoplamento Molecular , Estudos Observacionais como Assunto , Pandemias/prevenção & controle , Medidas de Resultados Relatados pelo Paciente , Ensaios Clínicos Controlados Aleatórios como Assunto , Receptores Histamínicos H2/metabolismo , SARS-CoV-2/efeitos dos fármacos , SARS-CoV-2/imunologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Resultado do Tratamento , Replicação Viral/efeitos dos fármacosRESUMO
Gastric ulcer is a painful lesion of the gastric mucosa which can be disabling, or even more very serious in the case of a perforation of the stomach and internal hemorrhage. Traditional pharmacopeias have shown the efficacy of various plant extracts in the treatment of this pathology. Some extracts from Opuntia ficus indica (OFI) have been proven to have medicinal therapeutic benefits. The aim of this study was to investigate the preventive and curative effects of OFI seed oil extracted by cold pressing on an ethanol-induced gastric ulcer model in rats. Gastroprotective activities of the oil were assessed as pretreatments prior to ethanol gavage of Wistar rats compared to reference drugs. Two oil dose effects were tested. Ulcer and gastric parameters were measured (ulcerated areas (mm2), % of ulcer inhibition, gastric juice volume and pH, and mucus weight). Macroscopical and microscopical assessments of the stomachs as well as gastric biopsy histological studies were carried out. OFI oil exhibited a high efficiency in the protection of the cytoarchitecture and function of the gastric mucosa against the severe damages provoked by ethanol intake. Ulcerated areas were very significantly reduced and the % of ulcer inhibition was the highest under OFI oil pretreatment. Mucus production was stimulated, gastric juice volume was reduced, and its pH was increased. Histopathological examination of H&E-stained biopsies collected from gastric mucosae from the different experimental groups confirmed the gastroprotective efficacy of OFI oil against ethanol-induced symptoms such as inflammation and damages like bleeding, erosions, lesions, necrosis, and ulcers. Furthermore, OFI oil treatment speeded-up the reduction of the surface of ethanol-induced ulcerated areas in a dose-dependent manner, leading to a time gain in the healing process. The healing rate reached 91% on day 2 and 99% on day 3, and a complete heal was attained at the fourth day under OFI oil treatment, while ulcer areas were still partially unhealed in all the other groups. The therapeutic effects of OFI oil against gastric ulcer could be mediated by its varied bioactive compounds that we have demonstrated in the analytical study. They could act synergistically or in a delayed manner to optimize the healing process through protective antioxidant properties, as well as an antagonism against histamine H2-receptors, a stimulation of the signaling pathways necessary for mucus and bicarbonate production, and reduction of inflammatory processes in the gastric mucosa. Additionally, OFI oil fatty acids (especially unsaturated) and triacylglycerols contribute to the reconstruction and the repair of the cell membrane lipid bilayer during the gastric ulcer healing process.
Assuntos
Opuntia/metabolismo , Óleos de Plantas/química , Substâncias Protetoras/farmacologia , Cicatrização/efeitos dos fármacos , Animais , Antioxidantes/química , Cromatografia Gasosa , Etanol/toxicidade , Ácidos Graxos Insaturados/farmacologia , Flavonoides/análise , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patologia , Antagonistas dos Receptores H2 da Histamina/química , Antagonistas dos Receptores H2 da Histamina/farmacologia , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Masculino , Extratos Vegetais/química , Óleos de Plantas/farmacologia , Óleos de Plantas/uso terapêutico , Substâncias Protetoras/química , Substâncias Protetoras/uso terapêutico , Ratos , Ratos Wistar , Receptores Histamínicos H2/química , Receptores Histamínicos H2/metabolismo , Sementes/metabolismo , Transdução de Sinais/efeitos dos fármacos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/patologia , Úlcera Gástrica/prevenção & controleRESUMO
We have reported that moderate prenatal alcohol exposure (PAE) elevates histamine H3 receptor-mediated inhibition of glutamatergic neurotransmission in dentate gyrus (DG), and that the H3 receptor antagonist ABT-239 ameliorates PAE-induced deficits in DG long-term potentiation. Here, we investigated whether PAE alters other markers of histaminergic neurotransmission. Long-Evans rat dams voluntarily consumed either a 0% or a 5% ethanol solution 4 h each day throughout gestation. Young adult female offspring from each prenatal treatment group were used in histidine decarboxylase (HDC) immunohistochemical studies of histamine neuron number in ventral hypothalamus, quantitative Western blotting studies of HDC expression in multiple brain regions, radiohistochemical studies of H2 receptor density in multiple brain regions, and in biochemical studies of H2 receptor-effector coupling in dentate gyrus. Rat dams consumed a mean of 1.90 g of ethanol/kg/day during pregnancy. This level of consumption did not affect maternal weight gain, offspring birth weight, or litter size. PAE did not affect the number of HDC-positive neurons in ventral hypothalamus. However, HDC expression was reduced in frontal cortex, dentate gyrus, and cerebellum of PAE rats compared to controls. Specific [125I]-iodoaminopotentidine binding to H2 receptors was not altered in any of the brain regions measured, nor was basal or H2 receptor agonist-stimulated cAMP accumulation in DG altered in PAE rats compared to controls. These results suggest that not all markers of histaminergic neurotransmission are altered by PAE. However, the observation that HDC levels were reduced in the same brain regions where elevated H3 receptor-effector coupling was observed previously raises the question of whether a cause-effect relationship exists between HDC expression and H3 receptor function in affected brain regions of PAE rats. This relationship, along with the question of why these effects occur in some, but not all brain regions, requires more-detailed investigation.
Assuntos
Cerebelo/metabolismo , Giro Denteado/metabolismo , Lobo Frontal/metabolismo , Histamina/metabolismo , Histidina Descarboxilase/biossíntese , Efeitos Tardios da Exposição Pré-Natal/metabolismo , Receptores Histamínicos H2/metabolismo , Animais , Contagem de Células , Feminino , Hipotálamo/efeitos dos fármacos , Masculino , Neurônios/efeitos dos fármacos , Gravidez , Ensaio Radioligante , RatosRESUMO
Peptic ulcer disease is one of the major challenges in public health globally and new evidence shows that it can be controlled by targeting the histamine H2 receptor (H2 R). Recently, a number of H2 R antagonists have been synthesized and used to block the action of histamine on the parietal cells in the stomach and decrease the acid production. In this study, we modeled the H2 R by homology modeling using the 3-D crystal structure and this model was validated based on free energy and amino acid residues present in the allowed regions of a Ramachandran plot. We used this 3-D model for screening of highly potent drugs using molecular docking. We found cimetidine, cimetex, and famotidine as the most potent drugs based on the binding affinity of drug-protein interactions. We also generated a cellular network for H2 R that could be useful for better understanding of cellular mechanism and drug targets. These findings provide a new insight into the development of suitable, specific, and effective anti-ulcer drugs for a most effective treatment of ulcerous diseases.
Assuntos
Antagonistas dos Receptores H2 da Histamina/farmacologia , Úlcera Péptica/tratamento farmacológico , Receptores Histamínicos H2/química , Receptores Histamínicos H2/metabolismo , Cristalografia por Raios X , Avaliação Pré-Clínica de Medicamentos , Antagonistas dos Receptores H2 da Histamina/química , Humanos , Ligação de Hidrogênio , Modelos Moleculares , Simulação de Acoplamento Molecular , Úlcera Péptica/metabolismo , Estrutura Secundária de Proteína , Homologia Estrutural de Proteína , Relação Estrutura-AtividadeRESUMO
The bioisosteric replacement of the acylguanidine moieties in dimeric histamine H2 receptor (H2R) agonists by carbamoylguanidine groups resulted in compounds with retained potencies and intrinsic activities, but considerably improved stability against hydrolytic cleavage. These compounds achieved up to 2500 times the potency of histamine when studied in [(35)S]GTPγS assays on recombinant human and guinea pig H2R. Unlike 3-(imidazol-4-yl)propyl substituted carbamoylguanidines, the corresponding 2-amino-4-methylthiazoles revealed selectivity over histamine receptor subtypes H1R, H3R and H4R in radioligand competition binding studies. H2R binding studies with three fluorescent compounds and one tritium-labeled ligand, synthesized from a chain-branched precursor, failed due to pronounced cellular accumulation and high non-specific binding. However, the dimeric H2R agonists proved to be useful pharmacological tools for functional studies on native cells, as demonstrated for selected compounds by cAMP accumulation and inhibition of fMLP-stimulated generation of reactive oxygen species in human monocytes.
Assuntos
Agonistas dos Receptores Histamínicos/química , Agonistas dos Receptores Histamínicos/farmacologia , Relação Estrutura-Atividade , Animais , Ligação Competitiva , Técnicas de Química Sintética , Avaliação Pré-Clínica de Medicamentos/métodos , Estabilidade de Medicamentos , Fluorescência , Guanidinas/química , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Cobaias , Agonistas dos Receptores Histamínicos/síntese química , Humanos , Ligantes , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Receptores Histamínicos H2/genética , Receptores Histamínicos H2/metabolismo , TrítioRESUMO
BACKGROUND: Both histamine H1- and H2-receptors (H2R) were found on regulatory T (Treg) cells; however, there is a paucity of information regarding the role of H2R in Treg function. This study aimed to investigate the effects of natural allergen stimulation and specific immunotherapy (SIT) on H2R expression in Treg cells in patients with allergic rhinitis (AR). METHODS: In this prospective, double-blind, placebo-controlled study 41 patients with AR were screened for 1 year and treated with SIT (n = 21) or placebo (n = 20) for the next 2 years. Fifteen healthy subjects were included as a control. Subsets of Treg cells that expressed H2R were assessed annually in the blood by flow cytometry: before, at the height of the pollen season, and after, at the end of the pollen season. In addition, total nasal symptom score, the use of rescue medication, and nasal eosinophilia were evaluated. RESULTS: Treg cells of AR patients slightly up-regulate H2R out of the pollen season. Natural allergen stimulation results in prompt up-regulation of H2R within these cells. SIT significantly decreased the number of Treg cells with increased expression of H2R in the blood exclusively at the height of pollen season, which, however, had no impact on the expression of H2R in Treg cells. SIT improved significantly the symptom score, rescue medication use, and decreased nasal eosinophilia. CONCLUSION: Natural pollen exposure results in up-regulation of H2R in Treg cells. Immunotherapy might transiently decrease the number of Treg-H2R(+) cells in the blood, which may be associated with their migration to the peripheral tissues. This study was part of the clinical trial registered in www.clinicaltrials.gov.
Assuntos
Alérgenos/uso terapêutico , Dessensibilização Imunológica/métodos , Eosinófilos/imunologia , Leucócitos Mononucleares/imunologia , Seios Paranasais/imunologia , Receptores Histamínicos H2/metabolismo , Rinite Alérgica Sazonal/diagnóstico , Rinite Alérgica Sazonal/terapia , Linfócitos T Reguladores/imunologia , Adulto , Alérgenos/imunologia , Antígenos de Plantas/efeitos adversos , Antígenos de Plantas/imunologia , Separação Celular , Método Duplo-Cego , Feminino , Citometria de Fluxo , Seguimentos , Regulação da Expressão Gênica , Humanos , Masculino , Seios Paranasais/patologia , Pólen/efeitos adversos , Estudos Prospectivos , Receptores Histamínicos H2/genética , Rinite Alérgica Sazonal/imunologia , Estações do Ano , Resultado do Tratamento , Adulto JovemRESUMO
A number of tremorogenic ß-carboline alkaloids such as harmane are naturally present in the human food chain. They are derived from medicinal plants such as Peganum harmala that have been used as folk medicine in anticancer therapy. In the present study, effects of the histaminergic system of the dorsal hippocampus (CA1) on harmane-induced amnesia were examined. One-trial step-down was used to assess memory retention in adult male mice. The results showed that pre-training intra-CA1 administration of histamine (5µg/mouse), ranitidine (H2 receptor antagonist; at the doses of 0.25 and 0.5µg/mouse) and pyrilamine (H1 receptor antagonist; at the dose of 5µg/mouse) decreased memory formation. Pre-training intraperitoneal (i.p.) administration of harmane (12mg/kg) also decreased memory formation. Moreover, pre-training intra-CA1 injection of a sub-threshold dose of histamine (2.5µg/mouse) could reverse harmane (12mg/kg, i.p.)-induced impairment of memory. On the other hand, pre-training intra-CA1 injection of sub-threshold doses of ranitidine (0.0625µg/mouse) and pyrilamine (2.5µg/mouse) increased harmane-induced impairment of memory. In conclusion, the present findings suggest the involvement of the CA1 histaminergic system in harmane-induced impairment of memory formation.
Assuntos
Região CA1 Hipocampal/efeitos dos fármacos , Harmina/análogos & derivados , Memória/efeitos dos fármacos , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/metabolismo , Amnésia/induzido quimicamente , Amnésia/metabolismo , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Aprendizagem da Esquiva/fisiologia , Região CA1 Hipocampal/metabolismo , Harmina/toxicidade , Masculino , Memória/fisiologia , CamundongosRESUMO
UNLABELLED: The present study was designed to investigate the influence of Se deficiency on serum histamine concentration and the expression of histamine receptor in the jejunum of chickens. Forty neonatal chickens were randomly divided into two groups. Experimental chickens were fed a low-Se diet (0.034 mg/kg), whereas chickens in the control group were fed a diet with a Se level of 0.229 mg/kg. Ten chickens were sacrificed on days 30, 45, 60 and 75. Blood and jejunum samples were collected. Histamine concentration in the jejunum was measured by ELISA, the jejunal mast cell (MC) ultrastructure was studied by transmission electron microscopy, and the expression level of histamine H2 receptor (H2R) mRNA in the jejunum was examined using real-time PCR. RESULTS: The jejunal histamine concentration in chickens fed the low-Se diet was significantly higher than that in the control group (P < 0.01). Se deficiency induced degranulation of MC in the jejunum of chickens in the low-Se diet group; their cytoplasm was filled with fused granules and vacuoles. The expression level of jejunal H2R mRNA in chickens fed the low-Se diet was also significantly higher than that in the control group (P < 0.01). The results obtained suggest that Se deficiency stimulates MC degranulation and release of histamine, binding H2R promotes both regulation of digestion and cell proliferation while protects the jejunum from injury induced by Se deficiency.
Assuntos
Galinhas/fisiologia , Histamina/metabolismo , Jejuno/fisiologia , Receptores Histamínicos H2/metabolismo , Selênio/deficiência , Ração Animal/análise , Animais , Dieta/veterinária , Regulação da Expressão Gênica/fisiologia , Jejuno/citologia , Mastócitos/ultraestrutura , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores Histamínicos H2/genéticaRESUMO
BACKGROUND: Defective contractile motility of the gallbladder is an important factor for gallstone formation. Estrogen might increase the risk of gallstones and cholecystitis, and estradiol inhibits the contractile activity of isolated strips of guinea pig gallbladder. The potential risks associated with hormone replacement therapy (HRT) include symptomatic gallstones. Phytoestrogen have been used to treat menopause syndromes by replacing traditional estrogen. This experiment aimed to determine the effects of the phytoestrogen genistein on the contractile response of smooth muscle strips isolated from guinea pig gallbladder and its possible mechanism of action. METHODS: Guinea pigs were sacrificed to remove the whole gallbladder. Two or three smooth muscle strips were cut longitudinally. Each strip was suspended in a tissue chamber containing Krebs solution. After 2 hours of equilibration, contractile response indexes were recorded. Different concentrations of genistein were added to the chamber and the contractile responses were measured. Each antagonist was added 2 minutes before genistein to study possible mechanisms. The effect of genistein on calcium-dependent contraction curves and biphasic contraction in calcium-free Krebs solution were measured. RESULTS: Genistein decreased the resting tension dose-dependently, and reduced the mean contractile amplitude and frequency in gallbladder strips. Ranitidine partly inhibited the effect of genistein, but methylene blue, Nomega-nitro-L-arginine, and propranolol hydrochloride did not influence this action. Genistein had no significant effects on calcium-dependent contraction. Genistein reduced the first contraction induced by acetylcholine chloride, but did not affect the second contraction caused by CaCl2. CONCLUSIONS: Genistein relaxed smooth muscle isolated from the gallbladder of guinea pigs and this might contribute to the formation of gallstones. The inhibitory action might be related to H2 receptors and the release of intracellular Ca2+ from sarcoplasmic reticulum. Replacing traditional estrogen with phytoestrogen to treat menopause syndromes may increase the risk of gallstone formation.
Assuntos
Vesícula Biliar/efeitos dos fármacos , Genisteína/farmacologia , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Fitoestrógenos/farmacologia , Animais , Cálcio/metabolismo , Relação Dose-Resposta a Droga , Feminino , Vesícula Biliar/metabolismo , Cálculos Biliares/induzido quimicamente , Genisteína/efeitos adversos , Cobaias , Técnicas In Vitro , Masculino , Músculo Liso/metabolismo , Fitoestrógenos/efeitos adversos , Receptores Histamínicos H2/efeitos dos fármacos , Receptores Histamínicos H2/metabolismo , Retículo Sarcoplasmático/efeitos dos fármacos , Retículo Sarcoplasmático/metabolismo , Transdução de Sinais/efeitos dos fármacosRESUMO
N1-Aryl(heteroaryl)alkyl-N2-[3-(1H-imidazol-4-yl)propyl]guanidines are potent histamine H2-receptor (H2R) agonists, but their applicability is compromised by the lack of oral bioavailability and CNS penetration. To improve pharmacokinetics, we introduced carbonyl instead of methylene adjacent to the guanidine moiety, decreasing the basicity of the novel H2R agonists by 4-5 orders of magnitude. Some acylguanidines with one phenyl ring were even more potent than their diaryl analogues. As demonstrated by HPLC-MS, the acylguanidines (bioisosteres of the alkylguanidines) were absorbed from the gut of mice and detected in brain. In GTPase assays using recombinant receptors, acylguanidines were more potent at the guinea pig than at the human H2R. At the hH1R and hH3R, the compounds were weak to moderate antagonists or partial agonists. Moreover, potent partial hH4R agonists were identified. Receptor subtype selectivity depends on the imidazolylpropylguanidine moiety (privileged structure), opening an avenue to distinct pharmacological tools including potent H4R agonists.
Assuntos
Guanidinas/síntese química , Guanidinas/farmacologia , Agonistas dos Receptores Histamínicos/química , Agonistas dos Receptores Histamínicos/farmacologia , Imidazóis/síntese química , Imidazóis/farmacologia , Receptores Histamínicos H2/metabolismo , Acilação , Animais , Linhagem Celular , Cristalografia por Raios X , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Guanidinas/química , Cobaias , Agonistas dos Receptores Histamínicos/síntese química , Humanos , Imidazóis/química , Modelos Moleculares , Estrutura Molecular , Relação Estrutura-Atividade , Fatores de TempoRESUMO
Human prefrontal cortex is essential for high brain functions and its activity is modulated by multiple neurotransmitters, including histamine. However, the histamine receptors in this brain area have not been systematically studied so far. In situ hybridization and receptor binding autoradiography were employed to map and quantify the mRNA expression and receptor binding of three of the four histamine receptors (H(1), H(2), H(3)). mRNA expression and receptor binding of these three histamine receptors displayed characteristic laminar distribution patterns. Both H(1) and H(3) receptor mRNAs were mainly expressed in the deeper layers (H(1) in laminae V and VI; H(3) in lamina V), where most of the corticothalamic projections originate, whereas H(2) receptor mRNA was primarily expressed in the superficial layer II. Receptor ligand binding of these three histamine receptors displayed relatively even distribution patterns throughout the gray matter. However, higher densities of H(1) and H(3) receptor radioligand binding sites were seen in the middle layers III and IV that receive abundant thalamic inputs and where some of the apical dendrites of the deep-layer pyramidal neurons terminate, whereas higher density of H(2) receptor radioligand binding sites was seen in the superficial layers I-III. The results, together with data on histaminergic regulation of thalamic oscillations suggest that histamine regulates both cortico-cortical and thalamo-cortical circuits. As histamine receptors are also abundant in thalamus, histamine may be involved also in human diseases of the thalamocortical system.
Assuntos
Histamina/metabolismo , Neurônios/metabolismo , Córtex Pré-Frontal/metabolismo , Receptores Histamínicos/genética , Receptores Histamínicos/metabolismo , Adulto , Idoso , Ligação Competitiva/fisiologia , Dendritos/metabolismo , Feminino , Humanos , Hibridização In Situ , Ligantes , Masculino , Pessoa de Meia-Idade , Vias Neurais/metabolismo , Córtex Pré-Frontal/anatomia & histologia , Células Piramidais/metabolismo , RNA Mensageiro/metabolismo , Ensaio Radioligante , Receptores Histamínicos H1/genética , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/genética , Receptores Histamínicos H2/metabolismo , Receptores Histamínicos H3/genética , Receptores Histamínicos H3/metabolismo , Transmissão Sináptica/fisiologia , Tálamo/metabolismoRESUMO
The pain of migraine is often throbbing suggesting an important role for the cranial blood vessels and their innervation by the trigeminal nerve. It is proposed that clinically effective anti-migraine compounds, such as 5-HT(1B/1D) agonists, have actions that include inhibiting calcitonin gene-related peptide (CGRP) release from trigeminal nerves. Human studies suggest that histamine can induce migraine possibly by activating nitric oxide (NO) synthase to promote endogenous NO production. The present studies investigated the effect of histamine and its antagonists on the cranial blood vessels using intravital microscopy to assess directly the diameter of dural arteries in sodium pentobarbitone anaesthetised rats. Electrical stimulation of a closed cranial window produces, by local depolarisation of nerves, dural vessel dilation that is monitored continuously on-line using video-microscopy and a video dimension analyser. Histamine infusion caused immediate and reproducible dilation of meningeal blood vessels (103.5+/-6%; n=40) that could be blocked by H(1)- (mepyramine) and H(2) (famotidine)-receptor antagonists (P<0.05), as well as a nitric oxide synthase inhibitor (N(G)-nitro-L-arginine methylester; P<0.05). Neurogenic dural vasodilation was not inhibited by H(2)-receptor antagonists, but was significantly inhibited by a H(1)-receptor antagonist at the high dose of 10 mg/kg. The present studies demonstrate that histamine is likely to activate NO synthase to promote NO production. There is also evidence that H(1)-receptors may be present on trigeminal neurones as the H(1)-receptor antagonist inhibited neurogenic vasodilation, albeit at a large dose.
Assuntos
Dura-Máter/efeitos dos fármacos , Histamina/farmacologia , Artérias Meníngeas/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Dura-Máter/irrigação sanguínea , Estimulação Elétrica , Inibidores Enzimáticos/farmacologia , Famotidina/farmacologia , Antagonistas dos Receptores Histamínicos/farmacologia , Masculino , Artérias Meníngeas/fisiologia , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase/metabolismo , Pirilamina/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/metabolismo , Fatores de Tempo , Vasodilatação/fisiologiaRESUMO
The synthesis and biological evaluation of novel antagonists of the rat H(3) receptor are described. These compounds differ from prototypical H(3) antagonists in that they do not contain an imidazole moiety, but rather a substituted aminopyrrolidine moiety. A systematic modification of the substituents on the aminopyrrolidine ring was performed using pre-formatted precursor sets, where applicable, to afford several compounds with high affinity and selectivity for the H(3) receptor.
Assuntos
Antagonistas dos Receptores Histamínicos/síntese química , Antagonistas dos Receptores Histamínicos/farmacologia , Pirrolidinas/síntese química , Pirrolidinas/farmacologia , Receptores Histamínicos H3/efeitos dos fármacos , Acilação , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Avaliação Pré-Clínica de Medicamentos , Humanos , Técnicas In Vitro , Ligantes , Ratos , Receptores Histamínicos H1/efeitos dos fármacos , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/efeitos dos fármacos , Receptores Histamínicos H2/metabolismo , Relação Estrutura-AtividadeRESUMO
In several cell systems histamine has been shown to stimulate both adenylyl cyclase and phospholipase C through activation of a G protein-coupled H2 receptor. To analyze the bifurcating signal emanating from the activated H2 receptor and to identify the G proteins involved, H1 and H2 histamine receptors were functionally expressed in baculovirus-infected insect cells. Histamine challenge lead to concentration-dependent cAMP formation and Ca2+ mobilization in Sf9 cells infected with a virus encoding the H2 receptor, whereas H1 receptor stimulation only resulted in pronounced phospholipase C activation. To analyze the G protein coupling pattern of histamine receptors, activated G proteins were labeled with [alpha-32P]GTP azidoanilide and identified by selective immunoprecipitation. In insect cell membranes expressing H1 histamine receptors, histamine led to incorporation of the label into alpha q-like proteins, whereas activation of the H2 receptor resulted in labeling of alpha q- and alpha s-like G protein alpha-subunits. In COS cells transfected with H2 receptor complementary DNA, histamine caused concentration-dependent accumulation of cAMP and inositol phosphates; the latter effect was insensitive to pertussis toxin treatment. Histamine stimulation led to a pronounced increase in inositol phosphate production when complementary DNAs coding for alpha q, alpha 11, alpha 14, or alpha 15 G protein alpha-subunits were cotransfected. This increase was specific for Gq family members, as overexpression of alpha 12 or alpha s did not enhance histamine-stimulated phospholipase C activation. In membranes of guinea pig heart, addition of [alpha-32P]GTP azidoanilide resulted in labeling of alpha q and alpha 11 via the activated H1 and also via H2 receptors. These data demonstrate that dual signaling of the activated H2 histamine receptor is mediated by coupling of the receptor to Gs and Gq family members.
Assuntos
Proteínas de Ligação ao GTP/metabolismo , Receptores Histamínicos H2/metabolismo , Fosfolipases Tipo C/metabolismo , Toxina Adenilato Ciclase , Adenilil Ciclases/metabolismo , Animais , Baculoviridae/genética , Ligação Competitiva , Células COS/efeitos dos fármacos , Células COS/metabolismo , Membrana Celular/metabolismo , AMP Cíclico/biossíntese , Subunidades alfa Gs de Proteínas de Ligação ao GTP/metabolismo , Proteínas de Ligação ao GTP/imunologia , Guanidinas/metabolismo , Guanidinas/farmacologia , Cobaias , Histamina/farmacologia , Antagonistas dos Receptores H2 da Histamina/metabolismo , Antagonistas dos Receptores H2 da Histamina/farmacologia , Fosfatos de Inositol/biossíntese , Insetos/metabolismo , Insetos/virologia , Masculino , Toxina Pertussis , Piperidinas/metabolismo , Piperidinas/farmacologia , Pirilamina/metabolismo , Pirilamina/farmacologia , Receptores Histamínicos H1/genética , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Fatores de Virulência de Bordetella/farmacologiaRESUMO
The pharmacological mechanisms of allergic cough in the guinea pig were studied. Actively sensitized guinea pigs were exposed to aerosols of antigen to elicit coughing. In separate experiments, naive guinea pigs were exposed to aerosols of capsaicin to elicit coughing. Both allergic and capsaicin-induced cough were inhibited by loratadine (0.3-10 mg kg-1 p.o.) and chlorpheniramine (0.1-3.0 mg kg-1 p.o.). Neither cimetidine (10 mg kg-1 s.c.), nor thioperamide (3-10 mg kg-1 s.c.), inhibited allergic or capsaicin-induced cough. Codeine (3-30 mg kg-1 p.o.), salbutamol (0.003-3.0 mg kg-1 s.c.) and ipratropium (0.03-1.0 mg kg-1 s.c.) inhibited both allergic and capsaicin-induced cough. Hexamethonium (10 and 30 mg kg-1 s.c.) inhibited allergic, but not capsaicin-induced cough. Allergic and capsaicin-induced cough were unaffected by phenidone (5.0 and 10.0 mg kg-1 s.c.). Indomethacin (5.0 and 10.0 mg kg-1 s.c.) had no effect on allergic cough but slightly inhibited capsaicin-induced cough. We conclude that allergic and capsaicin-induced cough are modulated by histamine H1 receptor and cholinergic mechanisms. Histamine H2 or histamine H3 receptor mechanisms, and lipoxygenase and cyclooxygenase products of arachidonic acid metabolism do not influence allergic and capsaicin-induced cough. Ganglionic mechanisms play a minor role in the production of allergic cough and no role in capsaicin-induced cough.
Assuntos
Antitussígenos/uso terapêutico , Capsaicina/toxicidade , Tosse/induzido quimicamente , Ovalbumina/toxicidade , Administração Oral , Aerossóis , Albuterol/administração & dosagem , Albuterol/uso terapêutico , Análise de Variância , Animais , Antitussígenos/farmacologia , Clorfeniramina/administração & dosagem , Clorfeniramina/uso terapêutico , Cimetidina/administração & dosagem , Cimetidina/uso terapêutico , Codeína/administração & dosagem , Codeína/uso terapêutico , Tosse/tratamento farmacológico , Hipersensibilidade a Drogas/tratamento farmacológico , Cobaias , Hexametônio/administração & dosagem , Hexametônio/uso terapêutico , Antagonistas dos Receptores Histamínicos , Indometacina/administração & dosagem , Indometacina/uso terapêutico , Injeções Subcutâneas , Ipratrópio/administração & dosagem , Ipratrópio/uso terapêutico , Loratadina/administração & dosagem , Loratadina/uso terapêutico , Masculino , Ovalbumina/imunologia , Piperidinas/administração & dosagem , Piperidinas/uso terapêutico , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/metabolismoRESUMO
Histamine is found in nerve cell bodies of the tuberomammillary nucleus in mammalian brain. This nucleus is prominent in human brain. Samples of human cerebelli obtained from neurosurgical operations were examined for the presence of histamine-containing nerve fibers. In all samples, a moderately dense network of histamine-immunoreactive fibers was seen in the molecular layer. These fibers ran parallel to the Purkinje cell layer after traversing it perpendicularly. Numerous fibers were also seen in the granular cell layer. The results suggest that the human cerebellar cortex receives a direct input from histamine-synthesizing hypothalamic neurons, as no other histamine-containing neurons have been found in human brain.
Assuntos
Cerebelo/citologia , Cerebelo/metabolismo , Histamina/metabolismo , Fibras Nervosas/metabolismo , Idoso , Córtex Cerebelar/citologia , Córtex Cerebelar/efeitos dos fármacos , Córtex Cerebelar/metabolismo , Feminino , Corantes Fluorescentes , Humanos , Hipotálamo/citologia , Hipotálamo/fisiologia , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Vias Neurais/citologia , Vias Neurais/fisiologia , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/metabolismo , Serotonina/metabolismoRESUMO
Conjugates of the A-chain of the mistletoe lectin I and histamine but not A-chain per se inhibit the capacity of spleen cells of the mouse to induce antibody response or graft-versus-host reaction by 90%. The conjugates killed 27% of the spleen cells, 60% of the T-, and 15% of the B-lymphocytes. The receptors for histamine could be shown to be of the H2-type, because only H2-antagonists inhibited the toxic influence of the conjugates. The results suggest the hypothesis that not only suppressor cells but at least the majority of the immunocompetent cells bear receptors for histamine. The A-chain-histamine conjugate represents an "affinotoxin" which is cytotoxic only after affinity binding on receptors of the target cell.
Assuntos
Citotoxicidade Imunológica , Histamina/análogos & derivados , Lectinas/imunologia , Linfócitos/imunologia , Preparações de Plantas , Proteínas de Plantas , Receptores Histamínicos H2/metabolismo , Receptores Histamínicos/metabolismo , Toxinas Biológicas/imunologia , Animais , Formação de Anticorpos , Linfócitos B/imunologia , Linfócitos B/metabolismo , Sítios de Ligação , Reação Enxerto-Hospedeiro , Histamina/imunologia , Imunossupressores , Técnicas In Vitro , Linfócitos/metabolismo , Camundongos , Receptores Histamínicos H2/imunologia , Proteínas Inativadoras de Ribossomos Tipo 2 , Baço/imunologia , Linfócitos T/imunologia , Linfócitos T/metabolismoAssuntos
Indóis/farmacologia , Pirazinas/farmacologia , Receptores Histamínicos H2/metabolismo , Receptores Histamínicos/metabolismo , Animais , Pressão Sanguínea/efeitos dos fármacos , Gatos , Avaliação Pré-Clínica de Medicamentos , Feminino , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Cobaias , Frequência Cardíaca/efeitos dos fármacos , Indóis/uso terapêutico , Masculino , Pirazinas/uso terapêutico , Coelhos , Ratos , Receptores Histamínicos H2/efeitos dos fármacos , Úlcera/tratamento farmacológicoRESUMO
1. When isolated perfused lungs from normal and ovalbumin sensitized guinea-pigs were challenged with histamine and 2-methylhistamine (agonists for H1-receptor), a release of thromboxane A2-like substance was observed. The effect of histamine on production of thromboxane A2 (TXA2) in sensitized lungs, was more pronounced than in normal lungs (P less than 0.01). 2. Specific activation of histamine H2-receptors in normal lungs with large doses (100 micrograms) of dimaprit and 4-methylhistamine, does not produce thromboxane-like or prostaglandin-like substances. 3. Perfusion of the lungs with pyrilamine (10 micrograms/ml) inhibited the release of arachidonate metabolites induced by histamine H1-receptor stimulation, whereas cimetidine (5 micrograms/ml) was ineffective. 4. It is concluded that only the stimulation of histamine H1-receptors appears to be responsible for generation of thromboxane A2 and other prostaglandin-like substances in normal guinea-pig lungs. In sensitized lungs, an increased ability of histamine to release TXA2 could be due to a possible interconversion of H2 into H1-receptors.